Psychotropic agents (antidepressants, etc.)

Psychotropic medications in preconception preparation: Safety and risks

The decision about pregnancy — it is a time of great hopes, but also significant stress. For women who take psychotropic medications, especially antidepressants, this period can be particularly anxiety‑provoking. Many questions arise: "Is it safe to continue taking the medication?", "Can they harm the future child?", "What is worse: the drug’s effect or the exacerbation of the illness?". This article aims to provide balanced, evidence‑based information that will help you, together with your doctor, make the right decision. Important: never stop or change the dosage of medication without consulting your psychiatrist and gynecologist.

Impact of mental health on fertility and pregnancy

Before talking about medication, it is important to understand that the mental disorder itself, especially during an exacerbation, can negatively affect the ability to conceive and the course of pregnancy. This is the main argument against abrupt discontinuation of drugs.

• Effect on hormonal balance. High levels of stress, anxiety or depression can disrupt the menstrual cycle and suppress ovulation. Chronic stress raises cortisol levels, which negatively impacts the reproductive system.
• Reduced libido. Psychological problems are often accompanied by a decrease in sexual desire, making conception more difficult.
• Risky behavior. During an exacerbation a person may neglect healthy nutrition, sleep schedule, and sometimes turn to harmful habits such as smoking or alcohol consumption. We discuss this in more detail in the article "Smoking, alcohol and harmful habits".
• Risks during pregnancy. Untreated depression or anxiety disorder in a pregnant woman increases the risk of pre‑eclampsia, preterm birth, low birth weight, and postpartum depression.

Thus, the main goal — to achieve a stable mental state during the planning stage. Often, the correctly selected medication therapy is the key to that stability.

Drug classes and their potential risks

The decision to take any medication during pregnancy — is always a weighing of the ratio "risk to the child vs. benefit to the mother". There is no universal “safe” pill, but there are drugs with varying degrees of study and risk.

Most common groups of medications:

1. SSRIs (selective serotonin reuptake inhibitors). This is the most common group of antidepressants (fluoxetine, sertraline, escitalopram). They are considered the most studied and generally have a relatively low risk profile. Some studies point to a slight increase in the risk of certain heart defects or pulmonary hypertension in newborns, but this risk remains very low. Sertraline is often the drug of choice for pregnant and breastfeeding women.
2. SNRI (serotonin‑norepinephrine reuptake inhibitors). Medications such as venlafaxine or duloxetine. There is less safety data compared with SSRIs, so they are prescribed with greater caution.
3. Tricyclic antidepressants (TCAs). An older group of drugs. Well studied, but have more side effects for the mother.
4. Mood stabilizers (normothymics). These are drugs for treating bipolar disorder (lithium, valproic acid, lamotrigine). Valproic acid is categorically contraindicated when planning pregnancy because of the high risk of neural‑tube defects. Lithium and lamotrigine can be used, but only under very careful medical supervision.
5. Antipsychotics (neuroleptics). Used for treating psychoses, schizophrenia, sometimes bipolar disorder. The decision is made individually, with a preference for newer‑generation (atypical) agents.
6. Benzodiazepines. These are anti‑anxiety and hypnotic drugs (diazepam, alprazolam). They are tried to be avoided, especially in the first and third trimesters, because of the risk of developing "withdrawal syndrome" in the newborn.

Action strategy: Step‑by‑step to a safe pregnancy

If you are taking psychotropic medications and planning a child, you need a clear plan developed together with your medical team.

• Step 1: "Pre‑" consultation. The ideal option — to see a psychiatrist and gynecologist 3–6 months before the intended conception. This gives time to adjust therapy. We write about the importance of such a visit in the article "Pre‑conception consultation".
• Step 2: Assessment. The doctor will evaluate your current condition. If you are in a prolonged remission, a gradual dose reduction or complete discontinuation with a switch to psychotherapy may be considered.
• Step 3: Switch to a safer medication. If therapy is necessary, the doctor may suggest moving to a more studied and pregnancy‑safe drug (for example, from valproic acid to lamotrigine or from a less studied antidepressant to sertraline).
• Step 4: Selection of the minimal effective dose. The goal — to find the lowest dose that reliably controls your symptoms.
• Step 5: Adding non‑pharmacological methods. Psychotherapy (especially CBT), relaxation techniques, meditation, sport — all help strengthen mental health and possibly reduce the need for medication. Psychological readiness is the key to success, which we discuss here: "Psychological readiness for pregnancy".

Conclusions: An informed decision is the best decision

Caring for the mother’s mental health is one of the most important priorities when planning pregnancy. A stable and healthy mother is the best thing you can give your future child. The decision about taking psychotropic medications does not have a "right" or "wrong" answer. It is always an individual choice, based on a careful analysis of risks and benefits. Open dialogue with your doctors, partner support, and access to verified information will help you navigate this path confidently and calmly, making the decision that will be best for your family.

```